- Home
- SBFM vs VMAR Comparison
SBFM vs VMAR Comparison
Compare SBFM & VMAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- VMAR
- Stock Information
- Founded
- SBFM 2006
- VMAR 1995
- Country
- SBFM United States
- VMAR Canada
- Employees
- SBFM N/A
- VMAR N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- VMAR Marine Transportation
- Sector
- SBFM Health Care
- VMAR Industrials
- Exchange
- SBFM Nasdaq
- VMAR Nasdaq
- Market Cap
- SBFM 4.9M
- VMAR 5.1M
- IPO Year
- SBFM N/A
- VMAR 2020
- Fundamental
- Price
- SBFM $1.24
- VMAR $6.74
- Analyst Decision
- SBFM Strong Buy
- VMAR Strong Buy
- Analyst Count
- SBFM 1
- VMAR 1
- Target Price
- SBFM $15.00
- VMAR $2,700.00
- AVG Volume (30 Days)
- SBFM 790.9K
- VMAR 57.5K
- Earning Date
- SBFM 05-19-2025
- VMAR 04-08-2025
- Dividend Yield
- SBFM N/A
- VMAR N/A
- EPS Growth
- SBFM N/A
- VMAR N/A
- EPS
- SBFM N/A
- VMAR N/A
- Revenue
- SBFM $34,874,283.00
- VMAR $1,612,492.00
- Revenue This Year
- SBFM $192.48
- VMAR $120.43
- Revenue Next Year
- SBFM N/A
- VMAR N/A
- P/E Ratio
- SBFM N/A
- VMAR N/A
- Revenue Growth
- SBFM 44.75
- VMAR N/A
- 52 Week Low
- SBFM $1.17
- VMAR $4.04
- 52 Week High
- SBFM $23.20
- VMAR $1,039.50
- Technical
- Relative Strength Index (RSI)
- SBFM 37.73
- VMAR 56.14
- Support Level
- SBFM $1.24
- VMAR $6.28
- Resistance Level
- SBFM $1.45
- VMAR $7.61
- Average True Range (ATR)
- SBFM 0.12
- VMAR 0.60
- MACD
- SBFM 0.01
- VMAR 0.11
- Stochastic Oscillator
- SBFM 15.38
- VMAR 70.05
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About VMAR Vision Marine Technologies Inc.
Vision Marine Technologies Inc is in the business of designing and manufacturing electric outboard powertrain systems, power boats, and related technology and the renting of electric boats. The different models of the powerboats and electric boats manufactured by the company include Bruce 22, Fantail 217, Volt 180, and others. The company operates in two reportable business segments; Sale of electric boats and Rental of electric boats. The majority of the revenue for the company is generated from the Sale of electric boats segment. Geographically, the company generates revenue from its business in Canada, USA and other countries. A substantial portion of the overall revenue is generated from its business in USA.